Manuel F. B.
- Country
- Spain
- Department
- Medical Oncology Department
Research Overview
- Evaluation of ASP3082 in Adult Patients with Advanced Solid Tumors
- A Phase II Study of AMG 436 Monotherapy and Combination Therapy in Participants with Microsatellite Instability-High/Mismatch Repair Deficient (MSI-H/dMMR) Solid Tumors
- Phase II Trial of DB-1311 in Combination with BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Data & Insights
Has run more than one trial at 63 of 183 partner sites.
Specializations
Hematologic Malignancies
This investigator specializes in treating various forms of pediatric blood cancers, with particular emphasis on acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Their expertise extends to managing high-risk cases and developing innovative treatment approaches for children and adolescents.
- FLT3-ITD positive AML treatment
- B-cell precursor ALL management
- Infection prophylaxis in AML patients
Rare Pediatric Conditions
The investigator focuses on treating rare childhood conditions including Langerhans Cell Histiocytosis (LCH) and its various manifestations. Their work encompasses both single-system and multi-system disease presentations.
- Multi-system LCH management
- CNS-Risk lesion treatment
- Long-term sequelae prevention
Pediatric Solid Tumors
Their expertise includes treating complex pediatric solid tumors, specifically neuroblastoma and ependymoma. The investigator specializes in developing comprehensive treatment strategies incorporating surgery, chemotherapy, and radiotherapy approaches.
- High-risk neuroblastoma treatment
- Intracranial and spinal ependymoma management
- Multi-modal therapy optimization
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.